Sutaria Dhruvitkumar S, Badawi Mohamed, Phelps Mitch A, Schmittgen Thomas D
Division of Pharmaceutics and Pharmaceutical Sciences, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
Pharm Res. 2017 May;34(5):1053-1066. doi: 10.1007/s11095-017-2123-5. Epub 2017 Mar 17.
Extracellular vesicles (EVs) represent a class of cell secreted organelles which naturally contain biomolecular cargo such as miRNA, mRNA and proteins. EVs mediate intercellular communication, enabling the transfer of functional nucleic acids from the cell of origin to the recipient cells. In addition, EVs make an attractive delivery vehicle for therapeutics owing to their increased stability in circulation, biocompatibility, low immunogenicity and toxicity profiles. EVs can also be engineered to display targeting moieties on their surfaces which enables targeting to desired tissues, organs or cells. While much has been learned on the role of EVs as cell communicators, the field of therapeutic EV application is currently under development. Critical to the future success of EV delivery system is the description of methods by which therapeutics can be successfully and efficiently loaded within the EVs. Two methods of loading of EVs with therapeutic cargo exist, endogenous and exogenous loading. We have therefore focused this review on describing the various published approaches for loading EVs with therapeutics.
细胞外囊泡(EVs)是一类细胞分泌的细胞器,天然含有生物分子货物,如微小RNA(miRNA)、信使核糖核酸(mRNA)和蛋白质。EVs介导细胞间通讯,使功能性核酸从起源细胞转移到受体细胞。此外,由于EVs在循环中的稳定性增强、生物相容性好、免疫原性低和毒性特征,它们成为一种有吸引力的治疗药物递送载体。EVs还可以进行工程改造,使其表面展示靶向部分,从而能够靶向所需的组织、器官或细胞。虽然人们对EVs作为细胞通讯者的作用已经有了很多了解,但治疗性EV应用领域目前仍在发展中。EV递送系统未来成功的关键在于描述能够将治疗药物成功且高效地装载到EVs内的方法。存在两种将治疗性货物装载到EVs中的方法,即内源性装载和外源性装载。因此,我们在这篇综述中重点描述了各种已发表的用治疗药物装载EVs的方法。